Keywords: gilead, unveils, 1st-qtr, net, loss, 8m, usa-based
Gilead unveils 1st-qtr net loss of $3.8m
Article | 13 May 2002
USA-based Gilead Sciences has reported total revenues of $78.4 millionfor the first-quarter of 2002, up 35.6% compared with the like, year-earlier period. Revenues ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
